Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: The endothelial modulation in angiogenic therapy (EMAT) randomized controlled trial

被引：0
|
作者：
Chan, V.
Lortie, M.
Beanlands, R. S.
dekemp, R. A.
Rubens, F. D.
Suuronen, E. J.
DaSilva, J.
Sellke, F. W.
Stewart, D. J.
Mesana, T. G.
Ruel, M.
机构：
来源：
CANADIAN JOURNAL OF CARDIOLOGY | 2007年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
973
引用
收藏
页码：289C / 289C
页数：1
相关论文
共 29 条
  • [21] The effect of periodontal therapy on C-reactive protein, endothelial function, lipids and proinflammatory biomarkers in patients with stable coronary artery disease: study protocol for a randomized controlled trial
    Marco Aurélio Lumertz Saffi
    Mariana Vargas Furtado
    Márlon Munhoz Montenegro
    Ingrid Webb Josephson Ribeiro
    Cassio Kampits
    Eneida Rejane Rabelo-Silva
    Carisi Anne Polanczyk
    Cassiano Kuchenbecker Rösing
    Alex Nogueira Haas
    Trials, 14
  • [22] Efficacy and Safety of Oral Tofacitinib for Maintenance Therapy in Patients With Moderate to Severe Crohn's Disease: Results of a Phase 2B Randomized Placebo-Controlled Trial
    D'Haens, Geert R.
    Panaccione, Remo
    Higgins, Peter
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Moscariello, Michele
    Chan, Gary
    Healey, Paul J.
    Niezychowski, Wojciech
    Wang, Wenjin
    Marren, Amy
    Maller, Eric
    GASTROENTEROLOGY, 2016, 150 (04) : S183 - S183
  • [23] Efficacy and safety of serial atorvastatin load in Chinese patients undergoing elective percutaneous coronary intervention: results of the ISCAP (Intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) randomized controlled trial
    Zheng, Bo
    Jiang, Jie
    Liu, Huiliang
    Zhang, Jun
    Li, Hui
    Su, Xi
    Wang, Haichang
    Song, Zhiyuan
    Han, Yaling
    Lei, Han
    Cong, Hongliang
    Zhang, Zheng
    Ma, Yitong
    Wang, Jian'an
    Xu, Biao
    Sun, Yingxian
    Gao, Chuanyu
    Zheng, Yang
    Liu, Bin
    Huang, Dejia
    Li, Bao
    Huang, Congxin
    Yang, Tianlun
    Wan, Zheng
    Jia, Shaobin
    Chen, Dafang
    Ge, Junbo
    Huo, Yong
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2015, 17 (0B) : B47 - B56
  • [24] Impact of Atorvastatin Treatment in First-Degree Relatives of Patients With Premature Coronary Artery Disease With Endothelial Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial
    Hong, Sung-Jin
    Chang, Hyuk-Jae
    Park, Sungha
    Kang, Dae Ryong
    Shin, Sanghoon
    Cho, In-Jeong
    Shim, Chi Young
    Hong, Geu-Ru
    Ha, Jong-Won
    Chung, Namsik
    CLINICAL CARDIOLOGY, 2013, 36 (08) : 480 - 485
  • [25] Impact of 12 weeks oral niacin on endothelial function in patients with coronary artery disease: a prospective, randomized, double-blind, placebo-controlled, single-center clinical trial of phase IIIb
    Wild, P. S.
    Blankenberg, S.
    Ostad, M. A.
    Elsner, V.
    Stieber, F.
    Lackner, K. J.
    Muenzel, T. F.
    Warnholtz, A.
    EUROPEAN HEART JOURNAL, 2007, 28 : 742 - 743
  • [26] Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial
    Sawada, Takahiro
    Tsubata, Hideo
    Hashimoto, Naoko
    Takabe, Michinori
    Miyata, Taishi
    Aoki, Kosuke
    Yamashita, Soichiro
    Oishi, Shogo
    Osue, Tsuyoshi
    Yokoi, Kiminobu
    Tsukishiro, Yasue
    Onishi, Tetsuari
    Shimane, Akira
    Taniguchi, Yasuyo
    Yasaka, Yoshinori
    Ohara, Takeshi
    Kawai, Hiroya
    Yokoyama, Mitsuhiro
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [27] Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial
    Takahiro Sawada
    Hideo Tsubata
    Naoko Hashimoto
    Michinori Takabe
    Taishi Miyata
    Kosuke Aoki
    Soichiro Yamashita
    Shogo Oishi
    Tsuyoshi Osue
    Kiminobu Yokoi
    Yasue Tsukishiro
    Tetsuari Onishi
    Akira Shimane
    Yasuyo Taniguchi
    Yoshinori Yasaka
    Takeshi Ohara
    Hiroya Kawai
    Mitsuhiro Yokoyama
    Cardiovascular Diabetology, 15
  • [28] Intracoronary Injection of Autologous CD34+Cells Improves One-Year Left Ventricular Systolic Function in Patients with Diffuse Coronary Artery Disease and Preserved Cardiac Performance-A Randomized, Open-Label, Controlled Phase II Clinical Trial
    Sung, Pei-Hsun
    Li, Yi-Chen
    Lee, Mel S.
    Hsiao, Hao-Yi
    Ma, Ming-Chun
    Pei, Sung-Nan
    Chiang, Hsin-Ju
    Lee, Fan-Yen
    Yip, Hon-Kan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [29] KEVLAR: A phase 2b, multi-institutional, randomized, blinded, controlled trial to assess the safety and efficacy of two schedules of RRx-001 vs. standard of care in attenuating severe oral mucositis (SOM) in patients receiving concomitant chemoradiation (CRT) for the treatment of locally advanced squamous cell carcinomas (SCC) of the oral cavity (OC) or oropharynx (OPC)
    Reid, Tony R.
    Oronsky, Bryan
    Caroen, Scott
    Abrouk, Nacer
    Stirn, Meaghan
    Sonis, Stephen T.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
123